Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT

Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT

Conditions: Gestational Diabetes Mellitus; Pregnancy, High Risk
Interventions: Device: CGM device – Metformin group; Device: CGM device – Insulin group
Sponsors: Ohio State University; The George Washington University Biostatistics Center; DexCom, Inc.
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 9, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments